Skip to main content
Top
Published in: Breast Cancer 5/2016

01-09-2016 | Original Article

The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study

Authors: Kenichi Harano, Kan Yonemori, Akihiro Hirakawa, Chikako Shimizu, Noriyuki Katsumata, Akihiko Gemma, Yasuhiro Fujiwara, Kenji Tamura

Published in: Breast Cancer | Issue 5/2016

Login to get access

Abstract

Background

The social or familial factors influencing the location chosen for end-of-life (EOL) care for terminally ill breast cancer patients are unknown.

Methods

We retrospectively analyzed 195 patients with recurrent or progressive breast cancer who received anticancer treatment at the National Cancer Center Hospital between January 2008 and May 2012. Detailed data concerning the patients’ demographic, familial, and clinical characteristics were collected, and multivariate and Cox logistic regression analyses were performed to evaluate the impact of these characteristics on the place of EOL care and on survival, respectively.

Results

Sixty-eight patients (34.9 %) died in a hospital, 26 patients (13.3 %) at home, and 101 patients (51.8 %) in hospice. Most of the patients having caregivers received EOL care at palliative care facilities (hospice or home) [odds ratio (OR) 2.57; 95 % confidence interval (CI) 1–6.6; p = 0.05]. In contrast, patients with factors suggesting a clinically severe status (performance status ≥2, use of opioids, delirium, and ascites) more often received EOL care in a hospital. Among patients who received EOL care at hospice or home, patients with minor children received EOL care at home (OR 0.08; 95 % CI 0.02–0.38; p = 0.001). Patients with brain metastases chose hospice (OR 12.37; 95 % CI 2.25–68.13; p = 0.004). Furthermore, having a caregiver was associated with prolonged survival (hazard ratio 0.62; 95 % CI 0.39–0.97; p = 0.035).

Conclusion

Familial factors such as having children and caregivers significantly influenced the place of EOL care for terminally ill breast cancer patients.
Literature
2.
go back to reference Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3:287–300.CrossRefPubMed Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3:287–300.CrossRefPubMed
3.
go back to reference Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol. 2004;22:3458–65.CrossRefPubMed Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol. 2004;22:3458–65.CrossRefPubMed
4.
go back to reference Higginson IJ, Astin P, Dolan S. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med. 1998;12:353–63.CrossRefPubMed Higginson IJ, Astin P, Dolan S. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med. 1998;12:353–63.CrossRefPubMed
5.
go back to reference Bruera E, Russell N, Sweeney C, et al. Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol. 2002;20:2127–33.CrossRefPubMed Bruera E, Russell N, Sweeney C, et al. Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol. 2002;20:2127–33.CrossRefPubMed
6.
7.
go back to reference Sanjo M, Miyashita M, Morita T, et al. Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan. Ann Oncol. 2007;18:1539–47.CrossRefPubMed Sanjo M, Miyashita M, Morita T, et al. Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan. Ann Oncol. 2007;18:1539–47.CrossRefPubMed
8.
go back to reference Yamagishi A, Morita T, Miyashita M, et al. Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) study. Am J Hosp Palliat Care. 2008;25:412–8.PubMed Yamagishi A, Morita T, Miyashita M, et al. Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) study. Am J Hosp Palliat Care. 2008;25:412–8.PubMed
9.
go back to reference Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21:1133–8.CrossRefPubMed Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21:1133–8.CrossRefPubMed
10.
go back to reference Malin JL. Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol. 2004;22:3438–40.CrossRefPubMed Malin JL. Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol. 2004;22:3438–40.CrossRefPubMed
11.
go back to reference Alonso-Babarro A, Bruera E, Varela-Cerdeira M, et al. Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol. 2011;29:1159–67.CrossRefPubMedPubMedCentral Alonso-Babarro A, Bruera E, Varela-Cerdeira M, et al. Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol. 2011;29:1159–67.CrossRefPubMedPubMedCentral
12.
go back to reference Grendarova P, Sinnarajah A, Trotter T, et al. Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003 and 2010. Support Care Cancer. 2015;23:3059–67.CrossRefPubMedPubMedCentral Grendarova P, Sinnarajah A, Trotter T, et al. Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003 and 2010. Support Care Cancer. 2015;23:3059–67.CrossRefPubMedPubMedCentral
13.
go back to reference O’Connor TL, Ngamphaiboon N, Groman A, et al. Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center. J Palliat Med. 2015;18:50–5.CrossRefPubMed O’Connor TL, Ngamphaiboon N, Groman A, et al. Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center. J Palliat Med. 2015;18:50–5.CrossRefPubMed
14.
go back to reference Morita T, Oyama Y, Cheng SY, et al. Palliative care physicians’ attitudes toward patient autonomy and a good death in East Asian Countries. J Pain Symptom Manage. 2015;50(190–199):e191. Morita T, Oyama Y, Cheng SY, et al. Palliative care physicians’ attitudes toward patient autonomy and a good death in East Asian Countries. J Pain Symptom Manage. 2015;50(190–199):e191.
15.
go back to reference Morita T, Akechi T, Ikenaga M, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23:2637–44.CrossRefPubMed Morita T, Akechi T, Ikenaga M, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23:2637–44.CrossRefPubMed
16.
go back to reference Okamura H, Uchitomi Y, Sasako M, et al. Guidelines for telling the truth to cancer patients. Japanese National Cancer Center. Jpn J Clin Oncol. 1998;28:1–4.CrossRefPubMed Okamura H, Uchitomi Y, Sasako M, et al. Guidelines for telling the truth to cancer patients. Japanese National Cancer Center. Jpn J Clin Oncol. 1998;28:1–4.CrossRefPubMed
17.
go back to reference Uchitomi Y, Yamawaki S. Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci. 1997;809:290–9.CrossRefPubMed Uchitomi Y, Yamawaki S. Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci. 1997;809:290–9.CrossRefPubMed
18.
go back to reference Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMed Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMed
19.
go back to reference Braga S, Miranda A, Fonseca R, et al. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis. Psycho-oncology. 2007;16:863–8.CrossRefPubMed Braga S, Miranda A, Fonseca R, et al. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis. Psycho-oncology. 2007;16:863–8.CrossRefPubMed
20.
go back to reference Kao S, Shafiq J, Vardy J, Adams D. Use of chemotherapy at end of life in oncology patients. Ann Oncol. 2009;20:1555–9.CrossRefPubMed Kao S, Shafiq J, Vardy J, Adams D. Use of chemotherapy at end of life in oncology patients. Ann Oncol. 2009;20:1555–9.CrossRefPubMed
21.
go back to reference Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29:1587–91.CrossRefPubMedPubMedCentral Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29:1587–91.CrossRefPubMedPubMedCentral
22.
go back to reference Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26:3860–6.CrossRefPubMedPubMedCentral Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26:3860–6.CrossRefPubMedPubMedCentral
23.
go back to reference Wentlandt K, Krzyzanowska MK, Swami N, et al. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30:4380–6.CrossRefPubMed Wentlandt K, Krzyzanowska MK, Swami N, et al. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30:4380–6.CrossRefPubMed
24.
go back to reference Akiyama M, Takebayashi T, Morita T, et al. Knowledge, beliefs, and concerns about opioids, palliative care, and homecare of advanced cancer patients: a nationwide survey in Japan. Support Care Cancer. 2012;20:923–31.CrossRefPubMed Akiyama M, Takebayashi T, Morita T, et al. Knowledge, beliefs, and concerns about opioids, palliative care, and homecare of advanced cancer patients: a nationwide survey in Japan. Support Care Cancer. 2012;20:923–31.CrossRefPubMed
25.
go back to reference Morita T, Miyashita M, Shibagaki M, et al. Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage. 2006;31:306–16.CrossRefPubMed Morita T, Miyashita M, Shibagaki M, et al. Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage. 2006;31:306–16.CrossRefPubMed
26.
go back to reference Nishie H, Mizobuchi S, Suzuki E, et al. Living will interest and preferred end-of-life care and death locations among Japanese adults 50 and over: a population-based survey. Acta Med Okayama. 2014;68:339–48.PubMed Nishie H, Mizobuchi S, Suzuki E, et al. Living will interest and preferred end-of-life care and death locations among Japanese adults 50 and over: a population-based survey. Acta Med Okayama. 2014;68:339–48.PubMed
Metadata
Title
The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study
Authors
Kenichi Harano
Kan Yonemori
Akihiro Hirakawa
Chikako Shimizu
Noriyuki Katsumata
Akihiko Gemma
Yasuhiro Fujiwara
Kenji Tamura
Publication date
01-09-2016
Publisher
Springer Japan
Published in
Breast Cancer / Issue 5/2016
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-015-0643-6

Other articles of this Issue 5/2016

Breast Cancer 5/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine